Introduction
Liver fibrosis is the scarring process that results from kinds of chronic liver diseases, such as viral hepatitis, alcoholic liver disease, non-alcoholic steatohepatitis, and autoimmune diseases etc, with the characteristics of increased production of extracellular matrix (ECM) components, particularly collagens in liver [1] [2] . Hepatic stellate cells (HSCs) play a central vast majority of ECM components. Activation of HSCs is controlled by a wide variety of cytokines, growth factors, and other molecules, such as reactive oxygen species [3] . Among HSC-activating molecules, transforming growth factor-beta 1 HSC activation and proliferation. Activated HSCs are proliferating cells that secrete extracellular matrix proteins, includHSCs are a crucial cell type in the injured liver, and their actiprofiles [4] . Therefore, inhibition of HSC activation has been
Traditional Chinese Medicine (TCM) has potential use for the treatment of chronic diseases [5] . In addition, TCM has been an accepted practice in medical care throughout East Asia for thousands of years. Our previous study found that Danggui Buxue Tang (DBT) or Danggui Buxue Decoction-an ancient traditional Chinese herbal formula composed of Huangqi (Radix Astragali) and Danggui (Radix Angelica sinensis) with a weight ratio of 5:1-has proven to be effective in treating liver fibrosis, and the key molecular mechanism has been revealed to be related to the prevention of degradation of lipid peroxidation as well as inhibition of MMP-2/9 activities and anti-angiogenesis [6] [7] . DBT not only has a clear effect on liver fibrosis but also affects pulmonary fibrosis and renal fibrosis [8] [9] [10] [11] [12] .
To study the chemical composition of DBT, Yi et al first profiled 18 markers of Radix Astragali and Radix Angelica sinensis in DBT using HPLC-DAD/ELSD and LC-ESI-MS analytical methods [13] . Zhang et al compared three different ancient DBT formulas [14] . The results showed that DBT in a Radix Astragali : Radix Angelica sinensis ratio of 5:1 has the highest amount of Radix Astragali -derived astragaloside III, astragaloside IV, calycosin and formononetin, as well as Radix Angelica sinensis-derived ferulic acid. This herbal decoction has stronger osteogenic, estrogenic, and erythropoietic effects than that generated by different herb ratios [14] . To date, chemi--lar, ferulic acid and Z-ligustilide from Radix Angelica sinensis and calycosin, formononetin and astragaloside IV from Radix Astragali [13, [15] [16] [17] [18] [19] [20] [21] . However, the active components of DBT that ingredients from DBT that are commercially available from the Shanghai Winherb Medical S&T Development Co, Ltd [22] as the basis of study.
In the present study, we observed the active components of DBT on LX-2 cells and calculated the combination index using the Chou-Talalay method. We then examined the effect of the treated C57BL/6 mouse model with a hepatic damage and cells and liver tissues was evaluated.
Materials and methods

Materials and reagents
was obtained from the Tokyo KaSei Industry Co, Ltd (Tokyo, Japan). All other chemicals and solvents used were of analytiChemicals Co, Ltd (Shanghai, China). Levistilide A, astragaloside I, calycosin and other components were all purchased from the Shanghai Winherb Medical Science Co, Ltd (Shanghai, China). The purity of these standards as determined by HPLC was more than 98%. Antibodies were obtained from -dase (HRP)-conjugated secondary antibodies (Santa Cruz Bioindicated in the relevant sections. Media and reagents for cell culture were acquired from Invitrogen (Life Technologies Corporation, CA, USA). All other chemicals were purchased from Sigma Chemical Co (St Louis, MO, USA)
Cell culture
The LX-2 cell line, a spontaneously immortalized human cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/mL of penicillin, and 100 U/mL of streptomycin. LX-2 cells were grown in a humidified incubator at 37 ºC in a 5% CO 2 atmosphere.
LX-2 cell viability and proliferation assay Cell viability and proliferation assays were performed using Cell Counting Beyotime Biotechnology, Haimen, cells (3.5×10 3 in DMEM medium with 10% FBS for 24 h. Levistilide A, astragaloside I, calycosin, sb431542 and other components were dissolved in DMSO at a concentration of 100 mmol/L and diluted with DMEM. Ten-fold serial dilutions were made -pounds were added to cells and incubated at 37 °C with 5% CO 2 for 48 h. The medium was removed by aspiration, and 90 added to each well. The plates were incubated for a further 2 h at 37 °C, and the absorbance at 450 nm was measured using a microplate reader (model 550, Bio-Rad Laboratories, Hercules, CA, USA). The percentage of growth is shown relative to untreated controls. Each experiment was performed independently at least three times.
LX-2 cell activation and inhibition assay LX-2 cells (3.5×10 3 plates in DMEM containing 10% FBS. After 24 h, cells were washed twice with PBS and fresh DMEM without FBS was added to the culture dish for 12 h of starvation. Then, various concentrations of levistilide A, astragaloside I, calycosin and other components were diluted in DMEM with 10 ng/mL positive control. Cells were cultured for a further 48 h. The -each well. The plates were incubated for a further 2 h at 37 °C and the absorbance at 450 nm was measured; the percentage of growth is shown relative to untreated controls. Each experiment was performed independently at least three times.
Chou-Talalay method
The Combination Index (CI) was calculated to determine whether the drugs interacted synergistically, additively, or antagonistically. CI was calculated by the following equation:
, where D 1 is the concentration of a drug necessary to achieve a particular effect in the combination; (Dm) 1 is the concentration of the same drug that produces an identical effect by itself; D 2 is the concentration of the second drug that will produce a particular effect in the combination; and (Dm) 2 is the concentration of the second drug that produces an identical effect by itself. CI>1 indicates antagonism, CI<1 indicates synergy, and CI=1
indicates additivity [23] [24] [25] [26] . Two independent experiments were performed to obtain the CI.
For immunofluorescence, LX-2 cells (3.5×10 3 were seeded into 96-well plates in DMEM containing 10% FBS. After 24 h, cells were washed twice with PBS and fresh DMEM without FBS was added to the culture dish for 12 h starvation. sb431542 was added. Cells were cultured for a further 24 h. with cold methanol: acetone (1:1) for 10 min on ice. After three rounds of extensive washing with PBS, cells were permeated with 0.05% saponin for 15 min. Cells were blocked with 5% bovine serum albumin in PBS buffer for 30 min at room tem-(1:100, A2547, Sigma, USA) or anti-collagen I antibody (1:100, 234167, Merck, Germany). Cells were subsequently stained with a FITC-conjugated secondary antibody. After washing, cells were double-stained with DAPI (Beyotime Biotechnology, Jiangsu, China) to visualize the nuclei. Images were taken using a Cellomics Array Scan VTI HCS Reader (Thermo -
Western blot
Western blot analyses were performed as described. Snap-frozen liver tissues were prepared in RIPA lysis buffer containing pH 7.4, 1 mmol/L EDTA, 1 mmol/L PMSF and 1×complete mini. Lysates were centrifuged at 10 000×g at 4 °C for 15 min to separate cytosol-enriched supernatant from nuclei-and membrane-enriched pellets. The protein concentrations were determined using the BCA protein assay kit mentioned above. Equal amount of proteins were separated by 10% SDS gel electrophoresis (SDS-PAGE) under denaturing and non-reducing conditions and were transferred to a nitrocellulose membrane. Membranes were blocked with 5% nonfat milk in TBST (20 primary antibody (1:1,000; Sigma-Aldrich, USA) at 4 °C overnight. After washing with TBST, blots were incubated with a horseradish-coupled secondary antibody in wash buffer. Signals were developed and immunoreactive bands were visualized using an ECL kit (Upstate Biotechnology, Lake Placid, Hercules, CA, USA).
This experiment was conducted according to local ethical guidelines (Shanghai University of TCM, Shanghai, China). -gen free (SPF) level, were provided by Sino-British SIPPR/BK Lab Animals (Shanghai, China). Mice were housed in a room and lighting (12 h artificial light and dark cycle) conditions, with free access to tap water and mouse chow. The standard fats, and 6.5% ash as well as a vitamin mixture. All mice were -trol (n=15), model control (n=18), sorafenib treatment (n=16), high-ALC formula (n=16) and low-dose ALC formula (n=16). Except for the normal control group, all mice were intraperiweight) three times a week for 4 weeks. On the third week, mice were treated with the positive control drug sorafenib and the ALC formula daily for two weeks. Sorafenib (6 mg/kg) or its vehicle (Cremophor/ethanol/sterile saline=1:1:3) was administered by intraperitoneal (ip) injection. The dosing volume was 2 mL/kg of body weight. The proportions of cremophor: ethanol: sterile saline were 12.5% cremophor, 12.5% ethanol, and 75% sterile saline. For animals receiving Sorafenib, -diately prior to application. Animals treated with the vehicle the drug. Mice in the normal control and model control were administered orally by gavage with vehicle once a day for four consecutive weeks at a dose of 2 mL/kg of body weight. From the second week to the forth week, mice in the high-dose ALC formula group were intraperitoneally injected with 44.21 mg/kg astragaloside I, 6 mg/kg levistilide A and 13.45 mg/kg calycosin once a day. In the group that received the low-dose ALC formula, mice were intraperitoneally injected with 22.11 mg/kg astragaloside I, 3 mg/kg levistilide A and 6.72 mg/kg calycosin once a day. Following pentobarbital sodium anesthesia, all mice were sacrificed 24 h after the last injection. Serum and liver samples were harvested. For histology and formalin and embedded in paraffin wax. Serum and liver
Cremophor EL was purchased from Sigma (Sigma-Aldrich).
Serum was obtained from C57BL/6 mouse blood and centrifuged at 4700 r/min for 15 min at 4 °C. The activities of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as well as the levels of serum albumin (Alb) were quantitated following the instructions provided by the manuChina), including the use of standards.
Hepatic hydroxyproline content determination
Hepatic hydroxyproline (Hyp) content was measured accordet al [27] . The concentration of Hyp in each sample was determined from a standard curve, which was generated from a series of known quantities Histopathological assessment of liver injury Liver specimens were fixed in a 10% formaldehyde solution and dehydrated in a graded alcohol series, embedded in paraffin blocks, and cut into 4-nm-thick slices. For histopathological examination, slices were stained using a standard hematoxylin and eosin (H&E) procedure. To investigate the hepatic collagen deposition, Sirius red-polarization staining was performed, and red staining was considered to indicate collagen deposition. Images were analyzed with a light microscope (Olympus BX40, Japan).
Liver tissue was homogenized in RIPA buffer, and the homogenate was centrifuged at 12 000×g for 30 min. The protein concentrations in the supernatant were determined using a BCA protein assay kit (Pierce, USA). Protein of each liver tissue -sis under reducing and denaturing conditions and was transferred to the nitrocellulose membrane. The membranes were blocked in 5% nonfat milk and Tris-buffered saline containing 0.1% Tween for 1 h at room temperature, followed by incuba-(1:400 dilution) and GAPDH overnight at 4 °C. The blots were washed with TBS-T three times, followed by incubation with the second antibody (anti-mouse, or anti-rabbit horseradish peroxidase-conjugated antibody) for 1 h at room temperature. After washing, the blots were developed with Supersignal West Pico chemiluminescent substrate and exposed to X-rays (Kodak, USA) according to the manufacturer's protocol. The density of the immunoreactive bands exposed on the films was quantified and corrected for the GAPDH signal with SmartView analysis software (Smartview, China).
All data are expressed as the mean±SD. Statistical tests were performed using SPSS software version 18.0. Differences between groups were assessed by nonparametric one-way -cant difference (LSD) post-hoc test, and P values lower than
Results
Astragaloside I, levistilide A and calycosin were the three main bioactive components for inhibiting proliferation and activation of LX-2 cells To identify the bioactive composition of DBT, we conducted an LX-2 cell-based screen of the fourteen main ingredients involved in the DBT. LX-2 cells were treated with fourSb431542 was used as positive control, which was known to inhibit the proliferation of LX-2 cells. The fourteen compounds, only calycosin and levistilide A inhibited the proliferation of LX-2 cells, with IC 50 values of 149. 93 and 30.82 no obvious inhibition of LX-2 cells (Table 1) .
to promote cell proliferation [28] the IC 50 -fore, the LX-2 cell activation model can be utilized to detect the activity of compounds. Interestingly, when LX-2 cells -ine, astragaloside I (A), calycosin (C) and levistilide A (L) all their EC 50 -low A, gentiopicrin, adenosine, rutin, swertiamain, sweroside, astragaioside I, astragaloside I and ononin had no obvious effects on the stellate cell activation model. In light of the relatively poor activity of adenosine, we believe that astragaloside I, calycosin and levistilide A are the three most effective bioactive components of DBT. Therefore, we chose astragaloside I, levistilide A and calycosin (Figure 1 ) to represent DBT and named the combination the "ALC formula."
The ALC formula had a potent synergistic effect that inhibits To test whether A and/or L and/or C exerted synergic or or combined drug treatment were analyzed by the medianeffect method, where combination indexes (CI) of less than, equal to, and more than 1 indicate synergistic, additive, and antagonistic effects, respectively [23] [24] [25] [26] . We found that A, L, and -ues <1 (Figure 2) , indicating synergic effects among the agents.
concentrations of A, L, C alone and in combination and found that ALC also had a strong synergistic effect on the LX-2 cell Chou and Talalay (Figure 3) .
on LX-2 of HSC activation [29] [30] . To further explore the effect of the -rescence staining or Western blot analysis. As shown in Figand collagen I compared to the normal group, (Figure 4A and C) and collagen I ( Figure 4B and D) . Among A, L, or C alone and in combination, we found that ALC also 4B and D) in LX-2 cells with effects similar to sb431542. West- model group was higher than in the normal group. However, -
In vivo assay demonstrating that the ALC formula exerted a hepatoprotective effect on dimethylnitrosamine-induced liver
To further evaluate the in vivo four weeks. From the third week, mice were treated with positive drugs and the ALC formula daily for two weeks.
serum ALT activity (P<0.01), but a lower Alb content (P<0.05), in the model group compared to the normal group (AST activbetween the normal group and model group). However, the ALC formula drastically reversed the above three biomarkers compared to the model group (Table 2) .
The ALC formula decreased collagen deposition and the two different histological methods, H&E staining ( Figure 5A ) and Sirius red staining ( Figure 5B and C). Histological analysis of livers from the control group indicated a normal liver lobular architecture with a central vein and radiating hepatic including gross hepatocyte fatty degeneration and necrosis, nodules or pseudolobules. Collagen semi-quantitative analy--cantly increased (P<0.01, Figure 5B and C). In the sorafenibtreated group, concurrent administration of sorafenib modmice. Interestingly, mice treated with the ALC formula (both low-and high-dose) showed much less liver inflammation and collagen accumulation in the liver compared to the model control (P the Hyp content assay. Compared to normal mice, model hepatic levels of Hyp (P<0.01) ( Figure 5D ). * P ** P vs # P ## P vs almost 2.5-fold higher in the model group than in the normal group. However, the ALC formula, which functions similarly to sorafenib, resulted in a more marked decrease than in the model group ( Figure 5E and F).
Discussion and conclusion accumulation of extracellular matrix proteins, including col-HCV infection, alcohol abuse, and nonalcoholic steatohepatitis [31] in chronic liver disease and can lead to cirrhosis. Therefore, [32] . Activation of HSCs leads to retinoid storage, remodeling of the ECM and production of growth factors and cytokines. Suppression of HSC activation has been suggested to be a therapeutic tar- [33] . Sorafenib, a multiple receptor tyrosine kinase inhibitor targeting the platelet-derived growth factor (PDGF) receptor and the Raf/extracellular-signalregulated kinase (ERK) signaling pathway, has been shown to induce suppression of collagen accumulation and HSCs growth. Sorafenib can be used as a potential therapeutic agent [34] [35] [36] . DBT is a classic formula from Chinese traditional medicine that has been widely used for the treatment of liver, kidney, lung and other organ fibrosis [8] [9] [10] [11] [12] [37] [38] [39] . However, DBT is a very complex mixture containing hundreds of components.
compounds, phthalides, organic acids, triterpene saponins and flavonoids [13] [14] [15] [16] [17] [18] [19] [20] [21] . Traditional Chinese medicines, due to longattracting increased global attention as excellent pools of bioactive compounds for the discovery of new drugs. However, the large numbers of other components in traditional Chinese medicines make screening and analysis of bioactive compo- [40] . It is believed that, at least in some formulae, multiple components could hit multiple targets and precise mechanisms of formulae remain to be addressed using ** P vs ## P vs molecular approaches, thus hampering the modernization of TCM [23] . Therefore, the exploration of effective components of DBT is very meaningful and may produce novel drugs.
The present study demonstrated that astragaloside I, levistilide A and calycosin may be the three main active anti-hepatic fibrosis components from DBT. They can inhibit activation of hepatic stellate cell line LX-2, which can be induced by their synergistic effect on activated LX-2 cells, and it was shown that the ALC could inhibited proliferation of LX-2 and (Figure 4) . including ALT and AST, which are parallel to liver damage [41] .
this study, treatment with the ALC formula markedly reduced the increased levels of AST and ALT. The Hyp content assay revealed that compared to normal mice, model mice showed a significant increase in Hyp content. The ALC formula at levels of Hyp (P<0.01) ( Figure 5D ). These results revealed Histological assessment indicated a protective effect of the liver has a lobular architecture with a central vein and radiating -cytes appears around the central vein together with marked collagen deposition. In the histopathological evaluation, severe structural damage, formation of dense fibrotic septa and proliferation of bile ducts in the presence of inflammatory cells were observed. Treatment with sorafenib and the ALC formula Activation of HSCs represents the key initial step in the -sentative feature of activated HSCs and is considered to be a [1] [2] [3] . In this study, we measured the western blot analysis in LX-2 cells and found that ALC also in vivo assay revealed that the ALC formula significantly decreased the group, in accordance with the above results of in vitro assays.
In conclusion, the present study established that astragaloside I, levistilide A and calycosin may be the main three active anti-hepatic fibrosis components from DBT, and this novel combination, the "ALC formula," has potent anti-fibrosis effects in vitro and in vitro. The ALC formula inhibited pro--
